ClinicalTrials.Veeva

Menu

US National TOP Registry

TransMedics logo

TransMedics

Status

Enrolling

Conditions

Lung Transplant

Treatments

Device: OCS Lung

Study type

Observational

Funder types

Industry

Identifiers

NCT06513091
OCS-LUN-TOP-II

Details and patient eligibility

About

The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

All lung transplant recipients

Trial design

10,000 participants in 2 patient groups

OCS Lung Transplant Recipients
Description:
The US National TOP Registry will enroll all liver transplant recipients who are transplanted with OCS-perfused donor lung(s) in the Registry.
Treatment:
Device: OCS Lung
Non-OCS Lung Transplant Recipients
Description:
Patients transplanted using other preservation modalities for benchmarking clinical outcomes.

Trial contacts and locations

1

Loading...

Central trial contact

Julia Church; Kausar Qidwai

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems